🇺🇸 FDA

Company profile · Sponsor

Clinuvel

Clinuvel Europe Limited

E47610F · EMA pharma GB
Pipeline
5
Drugs
0
Patents
0

Quick answer

Clinuvel (E47610F) is a pharma company. headquartered in GB. listed on EMA. NovaPharmaNews links 5 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E47610F
Exchange EMA
Company type pharma
Headquarters GB

Pipeline (5)

Search pipeline →

  1. SCENESSE 16 mg implant

    Clinuvel

    Vitiligo

    phase 3 small molecule active

    1 trial

  2. PRENUMBRA

    Clinuvel

    Healthy volunteers

    phase 2 small molecule active

    1 trial

  3. PRENUMBRA

    Clinuvel

    Parkinson's Disease

    phase 2 small molecule active

    1 trial

  4. PRENUMBRA

    Clinuvel

    Arterial Ischaemic Stroke (AIS)

    phase 2 small molecule active

    1 trial

  5. SCENESSE 16 mg implant

    Clinuvel

    Erythropoietic Protoporphyria (EPP)

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is Clinuvel?

Clinuvel (E47610F) is a pharma company. headquartered in GB. listed on EMA. NovaPharmaNews links 5 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Clinuvel sponsor?

We track 5 ClinicalTrials.gov-linked programs for Clinuvel, including SCENESSE 16 mg implant and 4 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Clinuvel company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.